Captor Therapeutics Spolka Akcyjna (WSE: CTX)
Poland
· Delayed Price · Currency is PLN
76.40
+0.40 (0.53%)
Sep 27, 2024, 5:00 PM CET
CTX Company Description
Captor Therapeutics Spolka Akcyjna, a biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases.
The company provides Targeted Protein Degradation technology that overcomes many existing drug limitations by removing proteins resistant to available therapeutics.
It has various therapeutic molecules in the preclinical stage. The company was incorporated in 2015 and is headquartered in Wroclaw, Poland.
Captor Therapeutics Spolka Akcyjna
Country | Poland |
Founded | 2015 |
Industry | Biotechnology |
Sector | Healthcare |
Employees | 105 |
CEO | Thomas Shepherd |
Contact Details
Address: ul. Dunska 11 Wroclaw, 54-427 Poland | |
Phone | 48 53 786 9089 |
Website | captortherapeutics.com |
Stock Details
Ticker Symbol | CTX |
Exchange | Warsaw Stock Exchange |
Fiscal Year | January - December |
Reporting Currency | PLN |
ISIN Number | PLCPTRT00014 |
SIC Code | 2836 |
Key Executives
Name | Position |
---|---|
Thomas Shepherd | Chief Executive Officer |
Anna Pawluk | Chief Operating Officer |